Officer and Director Files Intent to Sell $2.6M in Shares
CARL sits 23% above its 52-week low of $10.65 on elevated volume (3.8× avg).
Summary
An officer and director of Carlsmed, Inc. has filed a Form 144 indicating an intent to sell 197,855 shares of common stock, valued at approximately $2.6 million.
Key Events · Ownership and Investor Activity · CARL
-
Officer and Director Files Intent to Sell
Michael Cordonnier, an Officer and Director of Carlsmed, Inc., filed a Form 144 indicating an intent to sell 197,855 shares of common stock.
-
Significant Transaction Value
The proposed sale has an approximate market value of $2,629,881.29.
-
Shares Acquired via Options
The shares to be sold were acquired through options granted on January 8, 2021.
Analysis · CARL · Industrial Applications And Services
This Form 144 filing signals a significant intent to sell shares by Michael Cordonnier, who holds roles as both an officer and director at Carlsmed, Inc. The proposed sale of approximately $2.6 million represents a notable transaction. While the shares were acquired through options granted in 2021, the intent to sell by a key insider could be interpreted by investors as a signal regarding future prospects or personal liquidity needs. This filing follows recent positive earnings reports, making the timing of this insider sale noteworthy.
At the time of this filing, CARL was trading at $13.15 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $357.4M. The 52-week trading range was $10.65 to $17.19. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.